Spark

ONCE NASDAQ
96.85
-1.33
-1.35%
盘后: 96.85 0 0.00% 17:04 07/19 EDT
开盘
97.90
昨收
98.18
最高
98.99
最低
96.63
成交量
28.75万
成交均量(3M)
54.29万
52周最高
114.20
52周最低
34.53
换手率
0.75%
市值
37.20亿
分时
5日
1月
3月
1年
5年

相关股票

微牛行情栏目提供Spark ONCE股票价格,Spark股票实时行情,公司简介,财报信息,股本结构等,掌握美港股行情走势,开盘价,收盘价,总市值,换手率,市盈率,收益率等数据,及时把握美股港股投资机会。

公司介绍

Spark Therapeutics, Inc. is a gene therapy company. The Company focuses on treating orphan diseases. It has a pipeline of product candidates targeting multiple rare blinding conditions, hematologic disorders and neurodegenerative diseases. Its pipeline includes a product candidate targeting choroideremia (CHM), which is in a Phase I/II clinical trial and a product candidate for hemophilia A, which is in a Phase I/II clinical trial. Its product investigational candidate, voretigene neparvovec, is intended to treat a genetic blinding condition or inherited retinal disease (IRD). The programs targeting hematologic disorders include SPK-FIX, for which the lead product candidate, SPK-9001, is in a Phase I/II clinical trial for the treatment of hemophilia B, as well as SPK-FVIII for the treatment of hemophilia A. In its SPK-FVIII program for the treatment of hemophilia A, the Company has initiated a dose-escalating Phase I/II clinical trial for its lead product candidate, SPK-8011.
展开 >

最近浏览

名称
价格
涨跌幅